Medicare Part D Subsidy Ending in 2027: What Seniors Need to Know and Do Now

The federal government is ending a program that has been keeping Medicare prescription drug premiums lower for roughly 25 million Americans. Starting in 2027, seniors in standalone Part D plans could pay significantly more each month for the same coverage. Here is what is happening, why it matters, and what you can do about it — including how to make your voice heard in Congress.

What Is Happening

On July 29, 2026, the Trump administration announced it will end the Medicare Part D Premium Stabilization Demonstration at the close of 2026, one year earlier than originally planned. This temporary federal program, created by the Biden administration in 2024, has been subsidizing insurance companies to keep Part D prescription drug premiums stable while insurers adapted to the sweeping changes introduced by the Inflation Reduction Act of 2022.

The program was projected to cost taxpayers $9.8 billion over 2025 and 2026, according to a Government Accountability Office report. CMS Administrator Dr. Mehmet Oz characterized the subsidies as a "corporate bailout" that sent "BILLIONS of taxpayer money DIRECTLY to Big Insurance Companies." The administration argues that ending the program will save taxpayer dollars while still keeping premiums manageable.

Critics — including AARP, the Kaiser Family Foundation, and healthcare policy analysts — warn that the abrupt removal of these subsidies will directly increase monthly premiums for the 25 million Americans who rely on standalone Part D drug plans. The exact impact will not be known until insurers finalize their 2027 rates in September 2026.

How Much More Will You Pay?

The honest answer: nobody knows for certain yet, and anyone giving you a definitive number is guessing. Here is what the available data tells us.

In 2026, the average standalone Part D plan costs about $36 per month. The Premium Stabilization Demonstration has been reducing that average by approximately $16 per month, meaning without the subsidy, seniors could be paying $50 or more. CMS Administrator Oz has stated that most beneficiaries will see increases of "less than $10 per month," with some plans actually decreasing. Independent analysts are skeptical of that number.

The Kaiser Family Foundation has pointed out that even a $10 monthly increase on a $36 premium represents a 28% jump. For seniors on fixed incomes — many of whom are already stretching every dollar across groceries, utilities, and medical costs — that adds up to $120 or more per year on top of everything else.

What Is NOT Changing

It is important to separate the subsidy change from the broader Medicare drug reforms that are staying in place. The Inflation Reduction Act provisions that matter most to patients are not going away.

The annual out-of-pocket spending cap remains. Set at $2,100 in 2026, it rises to $2,400 in 2027 due to inflation adjustment. Before the IRA created this cap, there was no upper limit — seniors with expensive prescriptions could face $10,000 or more in annual out-of-pocket costs. That protection is still there.

The $35 monthly insulin cap is still in effect. Millions of diabetic seniors benefit from this provision, and it is not tied to the subsidy program.

Medicare drug price negotiations between the government and pharmaceutical companies continue. The first batch of negotiated prices took effect in 2026, covering some of the most expensive medications in the Medicare system.

The Medicare Prescription Payment Plan, which allows seniors to spread their out-of-pocket costs across the full year instead of paying them upfront at the pharmacy counter, also remains available.

The Hidden Risk: Getting Pushed Toward Medicare Advantage

Health policy experts have raised a concern that goes beyond the immediate premium increase. By making standalone Part D plans more expensive, the policy change creates a financial incentive for seniors to abandon traditional Medicare in favor of Medicare Advantage plans, which tend to have lower drug premiums (averaging about $8/month) because they bundle services.

This matters because Medicare Advantage plans come with trade-offs that are not always obvious upfront. They typically operate with narrower provider networks, meaning your preferred doctors and specialists may not be covered. They require more prior authorizations, which means the insurance company must approve certain treatments or medications before you can receive them. And critically, switching from traditional Medicare to Medicare Advantage can be a one-way door — if you try to switch back to traditional Medicare later, you may not be able to purchase a Medigap supplemental policy at standard rates, depending on your state and health status.

In short, some analysts worry that making traditional Medicare more expensive is a way to funnel beneficiaries into a system with more private insurer control and less patient choice.

What You Should Do Right Now

Make Your Voice Heard: Contact Your Members of Congress

This policy change was made by the executive branch — not by Congress. But Congress has the power to restore, replace, or modify the subsidy program through legislation. Your elected representatives need to hear from you. They pay attention to constituent contacts, especially on issues that affect large voting blocs like Medicare beneficiaries. Here is exactly how to reach them.

Phone calls are the most effective form of constituent contact, but emails and written letters also count. If you are a member of AARP, your local chapter may be organizing advocacy efforts — check aarp.org/advocacy for current campaigns. You can also reach out to organizations like the Medicare Rights Center and the National Council on Aging for additional resources.

Why This Matters Beyond Premiums

The Part D subsidy debate is part of a larger conversation about the future of Medicare itself. The Inflation Reduction Act represented the most significant expansion of Medicare drug benefits in the program's history, introducing the out-of-pocket cap, insulin price limits, and drug price negotiations that had been debated for decades. The Premium Stabilization Demonstration was designed to smooth the transition so that insurers would not pass all of their adjustment costs directly to seniors in the form of higher premiums.

Whether you view the subsidy as a necessary protection for seniors or an unnecessary handout to insurance companies, the practical effect of ending it will be felt in the wallets of 25 million Americans starting in January 2027. The new premium rates will be announced in September 2026 — right before midterm elections — giving voters a chance to evaluate the decision with real numbers in hand.

At RxGator, our mission is to help people find the lowest prescription prices regardless of their insurance status. But we also believe you deserve to understand the policy decisions that affect what you pay. This is one of those decisions. Stay informed, compare your options, and make your voice heard.

Key Dates to Remember